2026-10-11T21:42:56Z https://data.mendeley.com/oai

oai:data.mendeley.com/7n76dk9ssb.3 2026-06-30T04:09:50Z

Wang, Ruojun Real-world Comparison of Dupilumab and JAK Inhibitors in Atopic Dermatitis: Dose Reduction of JAKi is Associated with Significantly Reduced Efficacy Mendeley Data We conducted a retrospective cohort study comparing the effectiveness of dupilumab and oral JAKis in the management of AD using multicenter observational data from China. Dupilumab demonstrated comparable efficacy in improving skin lesions but lower response in pruritus relief compared with oral JAKis. Dose reduction led to significant compromised treatment effectiveness in oral JAKis. Clinical Analysis Atopic Dermatitis Propensity Analysis Yang, Zhihui Li, Hang Wang, Yang Dataset doi:10.17632/7n76dk9ssb.3 oai:data.mendeley.com/7n76dk9ssb.3 Creative Commons Attribution 4.0 International http://creativecommons.org/licenses/by/4.0 https://data.mendeley.com/datasets/7n76dk9ssb 2026-06-30T04:09:50Z